Junta editorial

Enrique Soto Pérez de Celis MD, PhD, FASCO, is a geriatric oncologist and the leader of the Cancer Care in the Older Adult Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) in Mexico City. He is a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and has published over 160 papers in peer- reviewed journals.

Dr. Soto completed an Internal Medicine residency at the INCMNSZ in Mexico City, and a fellowship in Medical Oncology at the same Institution. He also has master’s degree and a PhD in Medical Science from the National Autonomous University of Mexico. In 2017, Dr. Soto received the Conquer Cancer Foundation (CCF) Long Term International Fellowship (LIFE) which allowed him to complete a postgraduate fellowship in Geriatric Oncology under Dr. Arti Hurria at the Center for Cancer and Aging of City of Hope National Medical Center in Los Angeles. Dr. Soto is currently a Level F researcher in medical science at the Department of Geriatrics at INCMNSZ, where he oversees the Cancer Care in the Older Adult Clinic, the first multidisciplinary Geriatric Oncology clinic in Mexico. He is also a Level 3 member of the National System of Researchers of Mexico, and a member of the Board of the National Cancer Institute of Mexico.

Dr. Soto is the past recipient of the Excellence Award for Medical Oncology Residents from the Mexican Society of Oncology (2013), the International Development and Education Award (IDEA) from the CCF in 2014, the Young Investigator Award (YIA) from ASCO and the CCF in 2015, the LIFE Award from the CCF in 2016, and the CCF Career Development Award in 2019. He is a past member of ASCO’s Professional Development Committee, the former national representative of Mexico before the International Society of Geriatric Oncology (SIOG), and a former UICC Young Leader. 

Dr. Soto has collaborated closely with experts in the field of Global Oncology around the world, with a focus on narrowing inequities for disadvantaged populations such as older adults. His research focuses on the use of mobile technology to monitor older adults with cancer receiving chemotherapy and on global disparities in cancer care. He has participated in the Lancet Oncology Commissions on China, India, and Russia and Latin America, and in the Lancet Commission on Women, Power, and Cancer. His goals include fostering research initiatives from LMICs, with a focus on supporting young investigators in building successful careers.